A systematic review: Brain age gap as a promising early diagnostic biomarker for Alzheimer's disease
- PMID: 40494037
- DOI: 10.1016/j.jns.2025.123563
A systematic review: Brain age gap as a promising early diagnostic biomarker for Alzheimer's disease
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder for which there is currently no cure, and its incidence is on the rise. Early detection is essential for timely intervention and slowing the progression of the disease. While the brain structures of healthy aging individuals change gradually, the aging trajectories in AD patients deviate significantly. Recent advancements in deep learning have enabled the detection of subtle changes in brain structures using neuroimaging data. By developing brain age prediction models based on data from healthy individuals, it is possible to estimate brain age at various stages of AD progression and assess the Brain Age Gap (BAG)-the difference between predicted brain age and chronological age-which holds promise as an early diagnostic biomarker for AD. In recent years, the use of artificial intelligence, particularly deep learning, for brain age prediction has attracted considerable attention. This systematic review provides a comprehensive summary of the current state of research in this field, focusing on the progress and limitations of machine learning techniques for brain age prediction. We place particular emphasis on deep learning methods, addressing data sources, model development, and interpretability. Additionally, we analyze key challenges in the field, including site effects, bias correction, insufficient data, hardware requirements, model accuracy, and clinical applicability. Finally, we offer insights and recommendations for future research directions to address these challenges and further enhance the potential of BAG as a diagnostic tool for AD.
Keywords: Alzheimer's disease; Brain age gap; Deep learning; Early diagnosis; Neuroimaging.
Copyright © 2025 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The publication of this article has been approved by all authors, and they have no known competing financial interests or personal relationships.
Similar articles
-
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6. J Prev Alzheimers Dis. 2025. PMID: 39920001 Free PMC article.
-
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2. Cochrane Database Syst Rev. 2015. PMID: 25629415 Free PMC article.
-
The future of Alzheimer's disease risk prediction: a systematic review.Neurol Sci. 2025 Aug;46(8):3377-3390. doi: 10.1007/s10072-025-08167-x. Epub 2025 Apr 12. Neurol Sci. 2025. PMID: 40220257
-
Attention-driven hybrid deep learning and SVM model for early Alzheimer's diagnosis using neuroimaging fusion.BMC Med Inform Decis Mak. 2025 Jul 1;25(1):219. doi: 10.1186/s12911-025-03073-w. BMC Med Inform Decis Mak. 2025. PMID: 40597079 Free PMC article.
-
Development and Validation of a Brain Aging Biomarker in Middle-Aged and Older Adults: Deep Learning Approach.JMIR Aging. 2025 Aug 1;8:e73004. doi: 10.2196/73004. JMIR Aging. 2025. PMID: 40750095 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous